-
PROFESSIONAL QUALITY OF LIFE, BURNOUT AND SOCIAL SUPPORT AMONG HUNGARIAN PALLIATIVE NURSES
Mar 18, 2026, 21:38 PM -
BALANCING PRIVACY AND USABILITY IN REAL-WORLD DATA FOR OLDER ADULTS
Mar 18, 2026, 21:38 PM -
THE INCIDENCE OF INTRAUTERINE ADHESIONS FOLLOWING POTENTIALLY ADHESIOGENIC PROCEDURES: A SYSTEMATIC LITERATURE REVIEW WITH META-ANALYSES
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND CLINICAL MANAGEMENT OF ALZHEIMER’S DISEASE AGITATION
Mar 18, 2026, 21:38 PM -
ENHANCING THE CARE OF PATIENTS WITH PANCREATIC CANCER WITH NAVIGATOR FACILITATED ELECTRONIC PATIENT REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
POST-DISCHARGE TREATMENT PATHWAYS AFTER IV THERAPY FOR COMPLICATED UTI INCLUDING ACUTE PYELONEPHRITIS: IMPLICATIONS FOR LENGTH OF STAY, COSTS, AND TREATMENT FAILURE
Mar 18, 2026, 21:38 PM -
EVALUATION OF THE IMPLEMENTATION STATUS OF ADULT CANCER PROGRAM AT JIMMA MEDICAL CENTER, SOUTHWEST ETHIOPIA: PROCESS PROGRAM EVALUATION STUDY
Mar 18, 2026, 21:38 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH MULTIMORBIDITY (=2 CO-OCCURRING CONDITIONS IN AN INDIVIDUAL) AMONG UNITED STATES ADULTS WITH A DIAGNOSIS OF ASTHMA
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF CONSOLIDATION DURVALUMAB VERSUS OSIMERTINIB IN PATIENTS WITH UNRESECTABLE, STAGE III, EGFR-MUTATED NON-SMALL-CELL LUNG CANCER: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
ANTIHYPERTENSIVE TREATMENT PATTERNS BEFORE AND DURING PREGNANCY AMONG WOMEN WITH CHRONIC HYPERTENSION: A REAL-WORLD EHR STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF SUICIDAL IDEATION AND SELF-HARM AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH BREXPIPRAZOLE VERSUS OTHER ORAL ATYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ORPHAN MEDICINES IN LATIN AMERICA: A CROSS-COUNTRY VALUE AND ACCESS ANALYSIS
Mar 18, 2026, 21:38 PM -
PATIENT-CENTRIC PATHWAYS: SURVEYING TREATMENT ACCESS AND SUPPORT FOR RARE DISEASES, INCLUDING RARE CANCERS, IN EUROPE
Mar 18, 2026, 21:38 PM -
SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Mar 18, 2026, 21:38 PM -
WHY CURRENT INTERTEMPORAL DISCOUNTING METHODS ARE WRONG, HOW THEY DISTORT HEALTH TECHNOLOGY ASSESSMENT, COST-EFFECTIVENESS ANALYSIS AND ESTIMATES OF THE VALUE OF A LIFE-YEAR AT FULL HEALTH, AND HOW TO FIX THE PROBLEM
Mar 18, 2026, 21:38 PM -
THE BLOCKBUSTER BATTLE IN OBESITY: DO NEWER SEMAGLUTIDE DOSES CLOSE THE GAP? A TIME-COURSE MODEL-BASED NMA
Mar 18, 2026, 21:38 PM -
TRENDS IN INPATIENT COSTS AND DRIVERS OF HIGH-COST HOSPITALIZATIONS AMONG INDIVIDUALS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
COMPARISON OF BENEFIT DESIGN FOR DIABETES MEDICATIONS BETWEEN CONVENTIONAL MEDICARE ADVANTAGE PLANS AND CHRONIC CONDITION SPECIAL NEEDS PLANS
Mar 18, 2026, 21:38 PM -
THE DYNAMICS OF EXACERBATION-RELATED HEALTH-STATE TRANSITIONS IN UNCONTROLLED ASTHMA: A MARKOV-BASED MULTI-CRITERIA ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF CLOSED-SYSTEM AND OPEN-SYSTEM INFUSION OF HUMAN SERUM ALBUMIN IN ICU PATIENTS
Mar 18, 2026, 21:38 PM
